Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

A Novel Prediction Model for BK Virus Associated Hemorrhagic Cystitis in Acute Leukemia Patients Following Allogenic Hematopoietic Cell Transplantation: A Retrospective Cohort Study

Blood (2023) 142 (Supplement 1): 3531.

https://doi.org/10.1182/blood-2023-184415

Published: 2023

Journal Articles

Donor Macrophage Pyroptosis Contributed to the Development of aGVHD

Xueyan Sun, Qingyuan Qu, Yuxiu Chen, Menglin Li, Fengqi Liu, Qi Chen, Haixia Fu, Xiaohui Zhang, Xiangyu Zhao

Blood (2023) 142 (Supplement 1): 2194.

https://doi.org/10.1182/blood-2023-186441

Published: 2023

Journal Articles

Tacrolimus and Danazol Combination As a Second-Line Therapeutic Strategy for Steroid-Resistant or Relapsed Immune Thrombocytopenia: A Prospective, Randomized, Multicenter, Open-Label Study

Zhuo-Yu An, Yun He, Xiao-lu Zhu, Qiu-Sha Huang, Jin Wu, Haixia Fu, Yuan-Yuan Zhang, Ying-jun Chang, Xiangyu Zhao, Kaiyan Liu, Xiaohui Zhang

Blood (2023) 142 (Supplement 1): 2582.

https://doi.org/10.1182/blood-2023-188139

Published: 2023

Journal Articles

Virus-Specific CD8+ Stem Memory T Lymphocytes Display Enhanced Anti-Virus Responses

Xunhong Cao, Xuying Pei, Qiannan Shang, Xiangyu Zhao, Xiaojun Huang

Blood (2023) 142 (Supplement 1): 1181.

https://doi.org/10.1182/blood-2023-188897

Published: 2023

Journal Articles

Risk Factors and Prognostic Model for II-IV aGVHD in Patients with Engraftment Syndrome after Haploidentical Hematopoietic Stem Cell Transplantation

Song Wang, Yan Zhu, Xiaolu Zhu, Haixia Fu, Yun He, Fengrong Wang, Yuanyuan Zhang, Xiaodong Mo, Chenhua Yan, Yuhong Chen, Xiangyu Zhao, Yingjun Chang, Lanping Xu, Kaiyan Liu, Xiaojun Huang, Xiaohui Zhang

Blood (2023) 142 (Supplement 1): 2154.

https://doi.org/10.1182/blood-2023-184380

Published: 2023

Journal Articles

G-CSFR Is a Checkpoint of Natural Killer Cells Against Tumor

Xunhong Cao, Ting-Ting Han, Ming Zhao, Xie Juan, Ying-Jun Chang, Xiao-Jun Huang, Xiangyu Zhao

Blood (2023) 142 (Supplement 1): 3923.

https://doi.org/10.1182/blood-2023-182511

Published: 2023

Journal Articles

Pgam1 Regulate Adaptive NK Cells in Anti-Viral and Anti-Tumor Response

Juan Xie, Ming Zhao, Yiyang Ding, Qiannan Shang, Xunhong Cao, Xiangyu Zhao

Blood (2023) 142 (Supplement 1): 1185.

https://doi.org/10.1182/blood-2023-181537

Published: 2023

Journal Articles

Real-World Study of the Use of Iguratimod to Treat Chronic/Refractory ITP

Blood (2022) 140 (Supplement 1): 5567–5568.

https://doi.org/10.1182/blood-2022-167362

Published: 2022

Journal Articles

Costimulatory Molecule DNAM-1 Is Essential for Optimal NK Education Post Allogeneic Hematopoietic Stem Cell Transplantation

Qiannan Shang, MBBS, Xingxing Yu, Xunhong Cao, Xuefei Liu, Zhengli Xu, Yingjun Chang, Xiaosu Zhao, PhD, Yu Wang, Xiaohui Zhang, MD, Lanping Xu, Xiaojun Huang, MD, Xiangyu Zhao

Blood (2019) 134 (Supplement_1): 3291.

https://doi.org/10.1182/blood-2019-130593

Published: 2019

Journal Articles

Risk Factors and Different Therapeutic Patterns of Late-Onset Hemorrhagic Cystitis after Haploidentical Allogeneic Stem Cell Transplantation

Blood (2019) 134 (Supplement_1): 3261.

https://doi.org/10.1182/blood-2019-126230

Published: 2019

Journal Articles

Poor NKG2C+ Adaptive NK Cell Recovery at Early Stage after Allo-HSCT Increased the Occurrence of Refractory Cytomegalovirus Infection

Xingxing Yu, Xiangyu Zhao, Xunhong Cao, Xuefei Liu, Xuying Pei, PhD, Xiaosu Zhao, Ying-Jun Chang, Yu Wang, Lanping Xu, Xiaohui Zhang, Kaiyan Liu, MD PhD, Xiao Jun Huang

Blood (2018) 132 (Supplement 1): 360.

https://doi.org/10.1182/blood-2018-99-115772

Published: 2018

Journal Articles

First-Line Therapy with Donor Derived HCMV-Specific T Cells Reduce Persistent HCMV Infection after Allogenic Stem Cell Transplantation

Xiangyu Zhao, Xuying Pei, PhD, Xiaojun Huang, Ying-Jun Chang, Lanping Xu, Xiaohui Zhang, Kaiyan Liu, MD PhD

Blood (2018) 132 (Supplement 1): 727.

https://doi.org/10.1182/blood-2018-99-113923

Published: 2018

Journal Articles

Donor and Recipient HLA Class I Molecule Are Required for Maximum NK Cells Cytotoxicity Reconstitution Post Haploidentical Hematopoietic Stem Cells Transplantation

Xiangyu Zhao, MD, PhD, Xingxing Yu, Mingrui Huo, Xiaosu Zhao, Xueyi Luo, Yingjun Chang, Xiaohui Zhang, MD, Lanping Xu, Kaiyan Liu, MD, PhD, Xiao-Jun Huang, MD

Blood (2017) 130 (Supplement 1): 3257.

https://doi.org/10.1182/blood.V130.Suppl_1.3257.3257

Published: 2017

Journal Articles

Low Dose of Interleukin-2 Therapy Could Prevent Chronic Graft-Versus-Host Disease: A Randomized Study

Xiangyu Zhao, MD PhD, Xiaosu Zhao, Yutong Wang, Xin Qian, Yingjun Chang, Lanping Xu, Xiaohui Zhang, Chen Yuhong, Yu Wang, Wei Han, MD, Huan Chen, Chenhua Yan, Fengrong Wang, Wang Jingzhi, Yao Chen, Yuqian Sun, Kaiyan Liu, Xiaojun Huang

Blood (2014) 124 (21): 39.

https://doi.org/10.1182/blood.V124.21.39.39

Published: 2014

Journal Articles

Lacking Of Missing Killer-Immunoglobulin-Like Receptor Ligand In Recipients Can Predict Better Prognosis After HLA-Mismatched/Haploidentical Transplantation Without T Cells Depletion In Vitro In Chronic Myeloid Leukemia Patients

Xiangyu Zhao, Yingjun Chang, Ling-Ling Xu, Mingrui Huo, Xiaosu Zhao, Lanping Xu, Daihong Liu, Kaiyan Liu, Dan Li, Xiaojun Huang

Blood (2013) 122 (21): 2165.

https://doi.org/10.1182/blood.V122.21.2165.2165

Published: 2013

Journal Articles

Non-Traditional CD4+ CD25–CD69+ Regulatory T Cells Is Correlated To Leukemia Relapse After Allogeneic Hematopoietic Stem Cell Transplantation

Xiaosu Zhao, Xuhua Wang, Yingjun Chang, Xiangyu Zhao, Xiaohui Zhang, Daihong Liu, Lanping Xu, Kaiyan Liu, Xiaojun Huang, MD

Blood (2013) 122 (21): 3259.

https://doi.org/10.1182/blood.V122.21.3259.3259

Published: 2013

NARROW

A Novel Prediction Model for BK Virus Associated Hemorrhagic Cystitis in Acute Leukemia Patients Following Allogenic Hematopoietic Cell Transplantation: A Retrospective Cohort Study

Donor Macrophage Pyroptosis Contributed to the Development of aGVHD

Tacrolimus and Danazol Combination As a Second-Line Therapeutic Strategy for Steroid-Resistant or Relapsed Immune Thrombocytopenia: A Prospective, Randomized, Multicenter, Open-Label Study

Virus-Specific CD8+ Stem Memory T Lymphocytes Display Enhanced Anti-Virus Responses

Risk Factors and Prognostic Model for II-IV aGVHD in Patients with Engraftment Syndrome after Haploidentical Hematopoietic Stem Cell Transplantation

G-CSFR Is a Checkpoint of Natural Killer Cells Against Tumor

Pgam1 Regulate Adaptive NK Cells in Anti-Viral and Anti-Tumor Response

Real-World Study of the Use of Iguratimod to Treat Chronic/Refractory ITP

Costimulatory Molecule DNAM-1 Is Essential for Optimal NK Education Post Allogeneic Hematopoietic Stem Cell Transplantation

Risk Factors and Different Therapeutic Patterns of Late-Onset Hemorrhagic Cystitis after Haploidentical Allogeneic Stem Cell Transplantation

Poor NKG2C+ Adaptive NK Cell Recovery at Early Stage after Allo-HSCT Increased the Occurrence of Refractory Cytomegalovirus Infection

First-Line Therapy with Donor Derived HCMV-Specific T Cells Reduce Persistent HCMV Infection after Allogenic Stem Cell Transplantation

Donor and Recipient HLA Class I Molecule Are Required for Maximum NK Cells Cytotoxicity Reconstitution Post Haploidentical Hematopoietic Stem Cells Transplantation

Low Dose of Interleukin-2 Therapy Could Prevent Chronic Graft-Versus-Host Disease: A Randomized Study

Lacking Of Missing Killer-Immunoglobulin-Like Receptor Ligand In Recipients Can Predict Better Prognosis After HLA-Mismatched/Haploidentical Transplantation Without T Cells Depletion In Vitro In Chronic Myeloid Leukemia Patients

Non-Traditional CD4+ CD25–CD69+ Regulatory T Cells Is Correlated To Leukemia Relapse After Allogeneic Hematopoietic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only